About
Neurosoft Bioelectronics is a Swiss medtech company based in Geneva, specializing in the development of soft, elastic, and minimally invasive brain-computer interfaces (BCIs) and neural implants. The company originated as a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL). Their innovative technology features ultra-soft, conformable implantable electrodes that enhance bio-integration and safety, significantly reducing complications associated with traditional stiff electrodes. The flagship product is a fully implantable closed-loop BCI designed to treat severe tinnitus, a condition that affects many individuals and carries a high risk of suicide among patients. Additionally, Neurosoft is developing subdural electrodes for intraoperative monitoring during brain surgeries, aiming to improve clinical outcomes for conditions like epilepsy and brain tumors. The integration of advanced AI algorithms into their devices allows for the analysis of brain data, optimizing neuromodulation therapies and enabling personalized treatments. With a mission to lead in neurotechnology, Neurosoft Bioelectronics is committed to creating solutions that monitor, treat, and restore neurological functions.
Technologies
Keywords
Company Information
-
Employees 12
-
Founded 2020
-
Total Funding $3208381
Location
9 Chemin des Mines, Geneva, Geneva, Switzerland, 1202
